BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 270 filers reported holding BIONTECH SE in Q3 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,064,450 | -6.8% | 25,690 | +7.0% | 0.00% | 0.0% |
| Q1 2024 | $2,215,571 | -26.6% | 24,017 | -16.1% | 0.00% | -25.0% |
| Q4 2023 | $3,019,922 | +405.9% | 28,614 | +420.7% | 0.00% | +300.0% |
| Q3 2023 | $596,976 | -2.7% | 5,495 | -3.4% | 0.00% | 0.0% |
| Q2 2023 | $613,690 | -2.0% | 5,686 | +13.1% | 0.00% | 0.0% |
| Q1 2023 | $626,213 | -10.7% | 5,027 | +7.7% | 0.00% | 0.0% |
| Q4 2022 | $701,077 | +3.3% | 4,667 | -7.2% | 0.00% | 0.0% |
| Q3 2022 | $679,000 | -16.0% | 5,028 | -7.2% | 0.00% | -50.0% |
| Q2 2022 | $808,000 | +7.9% | 5,419 | +23.6% | 0.00% | +100.0% |
| Q1 2022 | $749,000 | -28.3% | 4,386 | +8.2% | 0.00% | -50.0% |
| Q4 2021 | $1,045,000 | +31.8% | 4,054 | +39.5% | 0.00% | +100.0% |
| Q3 2021 | $793,000 | – | 2,907 | +96800.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 3 | -99.5% | 0.00% | – |
| Q4 2020 | $46,000 | – | 567 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $11,947,443 | 19.99% |
| Quinn Opportunity Partners LLC | 683,287 | $54,908,943 | 6.24% |
| Krensavage Asset Management, LLC | 132,293 | $10,631 | 4.88% |
| Crocodile Capital Partners GmbH | 29,586 | $2,377,531 | 3.78% |
| ALTRINSIC GLOBAL ADVISORS LLC | 676,219 | $54,340,958 | 2.42% |
| FLOSSBACH VON STORCH AG | 4,379,483 | $351,935,254 | 1.48% |
| Systrade AG | 10,000 | $803,600 | 1.38% |
| HARDING LOEVNER LP | 2,926,761 | $235,224,417 | 1.30% |
| CenterBook Partners LP | 206,234 | $16,572,964 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 27,265 | $2,191,015 | 0.89% |